News Conference News ESC 2021 No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER Michael O'Riordan September 02, 2021
News Conference News ESC 2021 Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention Michael O'Riordan August 31, 2021
News Conference News ESC 2021 IAMI: Influenza Vaccine Beneficial for Post-MI Patients Michael O'Riordan August 30, 2021
News Conference News ESC 2021 Studies Reveal Surprising Benefits of Smoking Cessation and ‘Greenness’ L.A. McKeown August 28, 2021
News Daily News Colchicine Lowers CVD Risk No Matter When Past ACS Occurred: LoDoCo2 Michael O'Riordan August 26, 2021
News Opinion Editor's Corner ESC 2021 ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress Shelley Wood August 19, 2021
News Daily News ASCVD Risk in South Asians Far Exceeds Forecasts by Common Scores Shelley Wood July 12, 2021
News Daily News Big Downturn in CVD Procedures Seen During COVID-19’s First Wave Michael O'Riordan July 01, 2021
News Daily News Sleep Apnea Awareness, Treatment May Improve Some CVD Outcomes: AHA L.A. McKeown June 23, 2021
News Daily News LDL Cholesterol-Lowering Meds Rarely Intensified: GOULD Michael O'Riordan June 18, 2021
News Daily News Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors Michael O'Riordan June 16, 2021
News Daily News ASCVD and Cancer Diagnoses Pose Potentially Deadly Costs to Patients Caitlin E. Cox June 16, 2021
News Daily News Help for Evaluating Coronary Disease in People With High-Risk Jobs Todd Neale June 15, 2021
News Conference News ACC 2021 For Younger MI Survivors, Stress Boosts Adverse Outcomes Caitlin E. Cox May 13, 2021
News Conference News SCAI 2021 Cardiogenic Shock: Protocols, Clear Definitions Advance the Field Caitlin E. Cox April 30, 2021